EcoDrugPlus

Tyrosinase

Ensembl ID : ENSUPAG00010006775
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSUPAG00010021400
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSUPAG00010001822
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSUPAG00010021466
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSUPAG00010019402
Gene Symbol: UTRN
3 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSUPAG00010003509
Gene Symbol: VEGFA
1 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSUPAG00010002773
Gene Symbol: VDR
3 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSUPAG00010019665
Gene Symbol: VKORC1
1 Cross references
189 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSUPAG00010001959
Gene Symbol: XDH
3 Cross references
211 Possible Orthologues:

Ensembl ID : ENSUPAG00010016237
Gene Symbol: -
Cross references: -
418 Possible Orthologues:

Ensembl ID : ENSUPAG00010018363
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSUPAG00010018684
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).